PLUS PHARMA
ActiveSummary
PLUS PHARMA has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€151,542) and a net result of -€1,825. Equity remains stable across the filed financial years (±1.9% per year). The computed 12-month bankruptcy probability is 0.9% (low).
Directors
Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.